Jiali Chen
25 Taiping Street
Luzhou, 646000, China
Luzhou, 646000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Efficacy and safety of the combination of envafolimab and lenvatinib in unresectable hepatocellular carcinoma: a single-arm, multicentre, exploratory phase II clinical study.
Journal: Investigational new drugs
Published: July 04, 2024
Effect of external beam radiation therapy versus transcatheter arterial chemoembolization for non-diffuse hepatocellular carcinoma (≥ 5 cm): a multicenter experience over a ten-year period.
Journal: Frontiers in immunology
Published: July 24, 2023
Thymidine kinase 1 appears to be a marker for the prognosis of hepatocellular carcinoma based on a large-scale, multicenter study.
Journal: Journal of cancer research and clinical oncology
Published: June 26, 2023
PD-1 Inhibitors Combined with Antiangiogenic Therapy with or Without Transarterial Chemoembolization in the Treatment of Hepatocellular Carcinoma: A Propensity Matching Analysis.
Journal: Journal of hepatocellular carcinoma
Published: April 27, 2023
Construction and Validation of TACE Therapeutic Efficacy by ALR Score and Nomogram: A Large, Multicenter Study.
Journal: Journal of hepatocellular carcinoma
Published: March 29, 2023
Construction and validation of a nomogram for HBV-related hepatocellular carcinoma: A large, multicenter study.
Journal: Annals of hepatology
Published: December 27, 2022
External radiotherapy combined with sorafenib has better efficacy in unresectable hepatocellular carcinoma: a systematic review and meta-analysis.
Journal: Clinical and experimental medicine
Published: November 24, 2022
PD-1 inhibitors plus anti-angiogenic therapy with or without intensity-modulated radiotherapy for advanced hepatocellular carcinoma: A propensity score matching study.
Journal: Frontiers in immunology
Published: June 18, 2022
Heat-shock protein 90α is a potential prognostic and predictive biomarker in hepatocellular carcinoma: a large-scale and multicenter study.
Journal: Hepatology international
Published: May 08, 2022
Clinical efficacy and safety of external radiotherapy combined with sorafenib in the treatment of hepatocellular carcinoma: a systematic review and meta-analysis.
Journal: Annals of hepatology
Published: March 22, 2022
PD-L1 expression on circulating tumor cells can be a predictive biomarker to PD-1 inhibitors combined with radiotherapy and antiangiogenic therapy in advanced hepatocellular carcinoma.
Journal: Frontiers in oncology
Published: February 11, 2022
Gamma knife radiosurgery versus transcatheter arterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score matching study.
Journal: Hepatology international
Published: December 22, 2021
Showing 1-12 of 12
Last Updated: 09/26/2026